Imperagen raises £5 million to use quantum physics, AI on enzyme engineering

Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led by PXN Ventures, with participation from IQ Capital and Northern Gritstone.

By

Leave a Reply

Your email address will not be published. Required fields are marked *